Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Springer Nature Link
Log in

Aberrant microRNA expression in human cervical carcinomas

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 16 April 2011

Abstract

Because altered microRNAs (miRNAs) expression patterns have been observed in a variety of diseased tissues, miRNA expression was compared in human cervical cancer tissues relative to adjacent normal cervical tissues in the present study. Microarray chips with 924 probes were used to detect the expression of miRNAs in cervical cancer tissue and adjacent normal cervical tissue of 13 patients with cervical cancer (11 squamous cervical cancers, one cervical adenocarcinoma, and one cervical sarcoma), all of whom were infected with human papilloma virus (HPV) 16 and/or HPV18. Compared to the expression levels in normal cervical tissues, 18 miRNAs (1.9%) were significantly upregulated (increase of ≥2×), and 19 miRNAs (2.1%) were significantly downregulated (decrease of ≤0.5×) in cervical cancer tissues. miRNA expression was independent of lymph node involvement, vascular invasion, and pathological differentiation. Taken together, cervical cancer tissues have altered expression of miRNAs relative to adjacent normal tissues. Further studies are necessary to determine whether aberrant miRNA expression is related to the pathogenesis of cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CU-Cy3:

5′-phosphate-cytidyl-uridyl-cy3-3′

FBS:

Fetal bovine serum

FDR:

False discovery rate

FIGO:

International federation of gynecology and Obstetrics

HMEC:

Human mammary epithelial cell line

HPV:

Human papilloma virus

LOH:

Loss of heterozygosity (LOH)

miRNAs:

MicroRNAs

Q-PCR:

Quantitative PCR

SAM:

Significance analysis of microarrays

References

  1. Kim VN. Small RNAs: classification, biogenesis, and function. Mol Cells. 2005;19:1–15.

    Article  PubMed  CAS  Google Scholar 

  2. Lecellier CH, et al. A cellular microRNA mediates antiviral defense in human cells. Sci. 2005;308:557–60.

    Article  CAS  Google Scholar 

  3. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc–regulated microRNAs modulate E2F1 expression. Nat. 2005;435:839–43.

    Article  Google Scholar 

  4. Thomson JM, Parker J, Perou CM, Dang CV, Mendell JT. A custom microarray platform for analysis of microRNA gene expression. Nat Methods. 2004;1:47–53.

    Article  PubMed  CAS  Google Scholar 

  5. Barad O, et al. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004;14:2486–94.

    Article  PubMed  CAS  Google Scholar 

  6. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nat. 2005;435:682–6.

    Article  CAS  Google Scholar 

  7. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nat. 2006;442:82–5.

    CAS  Google Scholar 

  8. Burnside J, et al. Marek’s disease virus encodes microRNAs that map to meq and the latency-associated transcript. J Virol. 2006;80:8778–86.

    Article  PubMed  CAS  Google Scholar 

  9. Calin GA, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999–3004.

    Article  PubMed  CAS  Google Scholar 

  10. Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

    Article  PubMed  CAS  Google Scholar 

  11. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.

    Article  PubMed  CAS  Google Scholar 

  12. Nambaru L, Meenakumari B, Swaminathan R, Rajkumar T. Prognostic significance of HPV physical status and integration sites in cervical cancer. Asian Pac J Cancer Prev. 2009;10:355–60.

    PubMed  Google Scholar 

  13. Wang X, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 2008;e2557.

  14. Pang RT, et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis. 2010;31:1037–44.

    Article  PubMed  CAS  Google Scholar 

  15. Martinez I, et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene. 2008;27:2575–82.

    Article  PubMed  CAS  Google Scholar 

  16. Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 2010 Jul 22 [Epub ahead of print].

  17. Zhou X, et al. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol. 2010;117:287–90.

    Article  PubMed  CAS  Google Scholar 

  18. Hu X, et al. A microRNA expression signature for cervical cancer prognosis. Cancer Res. 2010;70:1441–8.

    Article  PubMed  CAS  Google Scholar 

  19. Zhang Y, et al. Microarray profile of micro-ribonucleic acid in tumor tissue from cervical squamous cell carcinoma without human papillomavirus. Obstet Gynaecol Res. 2009;35:842–9.

    Article  Google Scholar 

  20. Gao C, et al. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 2010;116:41–9.

    Article  PubMed  CAS  Google Scholar 

  21. Wu W, Lin Z, Zhuang Z, Liang X. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev. 2009;18:50–5.

    Article  PubMed  CAS  Google Scholar 

  22. Chou YT, et al. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res. 2010;70:8822–31.

    Article  PubMed  CAS  Google Scholar 

  23. Chen H, et al. miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem Biophys Res Commun. 2010;394:921–7.

    Article  PubMed  CAS  Google Scholar 

  24. Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat. 2010;13:57–66.

    Article  PubMed  CAS  Google Scholar 

  25. Blenkiron C, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007;8:R214.

    Article  PubMed  Google Scholar 

  26. Raponi M, et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 2009;69:5776–83.

    Article  PubMed  CAS  Google Scholar 

  27. Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA. MicroRNA expression variability in human cervical tissues. PLoS One. 2010;5:e11780.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China No. 30872743.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, The Second Affiliated Hospital of SunYat-sen University, 510120, Guangzhou, People’s Republic of China

    Qunxian Rao, Hui Zhou, Yongpai Peng, Jing Li & Zhongqiu Lin

Authors
  1. Qunxian Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yongpai Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhongqiu Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhongqiu Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rao, Q., Zhou, H., Peng, Y. et al. Aberrant microRNA expression in human cervical carcinomas. Med Oncol 29, 1242–1248 (2012). https://doi.org/10.1007/s12032-011-9830-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-9830-2

Keywords